UK markets open in 2 hours 35 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.19+0.06 (+0.98%)
At close: 04:00PM EDT
6.35 +0.16 (+2.58%)
After hours: 06:15PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
110,643
304,767
504,389
272,127
-
Other short-term investments
278,344
119,543
3,212
28,239
-
Total cash
388,987
424,310
507,601
300,366
-
Net receivables
56,950
50,599
29,413
8,646
-
Inventory
28,683
27,533
15,791
7,039
-
Other current assets
19,542
12,586
9,986
5,528
-
Total current assets
495,966
516,500
566,136
323,800
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
19,120
18,167
23,299
14,449
-
Accumulated depreciation
-11,210
-9,550
-8,113
-7,336
-
Net property, plant and equipment
7,910
8,617
15,186
7,113
-
Equity and other investments
0
18,077
6,829
-
0
Other long-term assets
13,084
6,806
6,472
3,802
-
Total non-current assets
20,994
33,500
22,015
10,915
-
Total assets
516,960
550,000
588,151
334,715
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
30,000
38,581
Accounts payable
20,893
14,356
27,808
18,713
-
Accrued liabilities
21,331
43,408
38,991
44,500
-
Deferred revenues
0
1,224
1,421
150
-
Other current liabilities
23,565
-
-
-
-
Total current liabilities
149,988
105,514
103,718
105,654
-
Non-current liabilities
Long-term debt
811,265
733,279
585,457
244,452
-
Total non-current liabilities
822,500
739,083
591,419
248,323
-
Total liabilities
972,488
844,597
695,137
353,977
-
Stockholders' equity
Common stock
2,058
1,879
1,843
1,769
-
Retained earnings
-1,681,159
-1,454,620
-1,207,504
-1,023,442
-
Accumulated other comprehensive income
1,337
26
177
3
-
Total stockholders' equity
-455,528
-294,597
-106,986
-19,262
-
Total liabilities and stockholders' equity
516,960
550,000
588,151
334,715
-